Archives

by in
Entry Author Date Location
Akebia, Trading M&A For an IPO, Follows Fast in Anemia Drug Race 06/09/14 Boston
Biotech IPO Slump Deepens as Alder Prices Below Range 05/08/14 Seattle
Alder BioPharmaceuticals Hits IPO Trail Looking for $115M 03/19/14 Seattle
ZS Pharma Raises $55M to Develop Drug to Treat Hyperkalemia 03/06/14 Texas
Flexion Prices IPO at $13, Heads to Nasdaq Tomorrow 02/11/14 Boston
Flexion Files for IPO, Seeks $86M to Develop Osteoarthritis Drugs 01/08/14 Boston
Foundation Medicine, Ophthotech Both Find Open Wallets on Wall Street 09/25/13 Boston
Ophthotech Prices IPO at $22 Per Share, Reels in $167M 09/24/13 New York
Ophthotech Eyes $85M IPO With Late-Stage Clinical Trial in Sight 08/15/13 New York
Cardeas Pharma Snags $34M For Antibiotic Against Hospital Infections 05/22/13 Seattle
Ceterix Orthopaedics Lands $19,500,000 Series B Round 01/22/13 San Francisco
Allakos Receives $32,000,000 Series A Funding Round 12/18/12 San Francisco
Flexion Therapeutics Obtains $20,000,000 Series B Funding 12/04/12 Boston
Thesan Pharmaceuticals Receives $16,000,000 Series A Round 11/01/12 San Diego
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Alder Biopharmaceuticals Receives $38,000,000 Series D Financing Round 04/19/12 Seattle
Inogen Garners $20,000,000 New Round 04/12/12 San Diego
Adimab, ImmunoGen, OvaScience, & More Boston Life Sciences News 04/06/12 Boston
Boston Deals: Funding for FRX, Allocure, Good Start, & FirstBest 04/03/12 Boston
AlloCure Secures $25,000,000 Series B Funding Round 04/02/12 Boston
Altheos Lands $12,500,000 Series A Financing Round 02/09/12 San Francisco
Elevation Pharmaceuticals Obtains $30,000,000 Series B Funding 01/04/12 San Diego
Raising Funds: AnaptysBio, Sonexa, Eclipse, NextDx, Naviscan 10/18/11 San Diego
Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M 09/07/11 San Diego
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug 07/21/11 San Diego
Cell Biosciences Boosts F Round, Buys Brightwell 05/13/11 San Francisco
Amira Cuts Half of Staff, Scientific Founders Exit as Company Seeks to Conserve Cash 11/23/10 San Diego
Light Sciences Oncology CEO Exits for New Job; Company Still Waiting for Pivotal Results 11/22/10 Seattle
Cell Biosciences Nabs $20M, Buys Convergent 10/14/10 San Francisco
Synosia Raises $30M, Strikes Deal With UCB Worth Up to $725M for Parkinson’s Drugs 10/12/10 San Francisco
Page 1 of 2 next page »